Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy

INTRODUCTION: Immunotherapy with checkpoint inhibitors is an efficient treatment for metastatic melanoma. Development of vitiligo upon immunotherapy represents a specific immune-related adverse event (irAE) diagnosed in 15% of patients and associated with a positive clinical response. Therefore, a d...

Descripción completa

Detalles Bibliográficos
Autores principales: Carbone, Maria Luigia, Capone, Alessia, Guercio, Marika, Reddel, Sofia, Silvestris, Domenico Alessandro, Lulli, Daniela, Ramondino, Carmela, Peluso, Daniele, Quintarelli, Concetta, Volpe, Elisabetta, Failla, Cristina Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482109/
https://www.ncbi.nlm.nih.gov/pubmed/37680638
http://dx.doi.org/10.3389/fimmu.2023.1197630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482109/
https://www.ncbi.nlm.nih.gov/pubmed/37680638
http://dx.doi.org/10.3389/fimmu.2023.1197630

Ejemplares similares